232 related articles for article (PubMed ID: 25175457)
1. Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia.
Ferraro L; Beggiato S; Borroto-Escuela DO; Ravani L; O'Connor WT; Tomasini MC; Borelli AC; Agnati LF; Antonelli T; Tanganelli S; Fuxe K
Curr Protein Pept Sci; 2014; 15(7):681-90. PubMed ID: 25175457
[TBL] [Abstract][Full Text] [Related]
2. Relevance of dopamine D(2)/neurotensin NTS1 and NMDA/neurotensin NTS1 receptor interaction in psychiatric and neurodegenerative disorders.
Tanganelli S; Antonelli T; Tomasini MC; Beggiato S; Fuxe K; Ferraro L
Curr Med Chem; 2012; 19(3):304-16. PubMed ID: 22335510
[TBL] [Abstract][Full Text] [Related]
3. Receptor-receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia.
Antonelli T; Tomasini MC; Fuxe K; Agnati LF; Tanganelli S; Ferraro L
J Neural Transm (Vienna); 2007 Jan; 114(1):105-13. PubMed ID: 16983483
[TBL] [Abstract][Full Text] [Related]
4. Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat.
Ferraro L; O'Connor WT; Beggiato S; Tomasini MC; Fuxe K; Tanganelli S; Antonelli T
Eur J Neurosci; 2012 Jan; 35(2):207-20. PubMed ID: 22211865
[TBL] [Abstract][Full Text] [Related]
5. Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons.
Jomphe C; Lemelin PL; Okano H; Kobayashi K; Trudeau LE
Eur J Neurosci; 2006 Nov; 24(10):2789-800. PubMed ID: 17116165
[TBL] [Abstract][Full Text] [Related]
6. Understanding the role of heteroreceptor complexes in the central nervous system.
Fuxe K; Borroto-Escuela D; Fisone G; Agnati LF; Tanganelli S
Curr Protein Pept Sci; 2014; 15(7):647. PubMed ID: 25256022
[TBL] [Abstract][Full Text] [Related]
7. Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.
Liang Y; Boules M; Li Z; Williams K; Miura T; Oliveros A; Richelson E
Neuropharmacology; 2010 Jun; 58(8):1199-205. PubMed ID: 20211191
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: counteraction by a NTR1-like receptor antagonist.
Díaz-Cabiale Z; Fuxe K; Narváez JA; Finetti S; Antonelli T; Tanganelli S; Ferraro L
Neuroreport; 2002 May; 13(6):763-6. PubMed ID: 11997683
[TBL] [Abstract][Full Text] [Related]
9. Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment.
Antonelli T; Fuxe K; Tomasini MC; Mazzoni E; Agnati LF; Tanganelli S; Ferraro L
Prog Neurobiol; 2007 Oct; 83(2):92-109. PubMed ID: 17673354
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A2A-D2 receptor-receptor interactions in putative heteromers in the regulation of the striato-pallidal gaba pathway: possible relevance for parkinson's disease and its treatment.
Beggiato S; Antonelli T; Tomasini MC; Borelli AC; Agnati LF; Tanganelli S; Fuxe K; Ferraro L
Curr Protein Pept Sci; 2014; 15(7):673-80. PubMed ID: 25175458
[TBL] [Abstract][Full Text] [Related]
11. Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin.
Fuxe K; Von Euler G; Agnati LF; Merlo Pich E; O'Connor WT; Tanganelli S; Li XM; Tinner B; Cintra A; Carani C
Ann N Y Acad Sci; 1992; 668():186-204. PubMed ID: 1361113
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: a receptor binding and microdialysis study.
Li XM; Ferraro L; Tanganelli S; O'Connor WT; Hasselrot U; Ungerstedt U; Fuxe K
J Neural Transm Gen Sect; 1995; 102(2):125-37. PubMed ID: 8748677
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat.
Ferraro L; O'Connor WT; Antonelli T; Fuxe K; Tanganelli S
Eur J Neurosci; 1997 Sep; 9(9):1838-46. PubMed ID: 9383206
[TBL] [Abstract][Full Text] [Related]
14. Electron microscopic dual labeling of high-affinity neurotensin and dopamine D2 receptors in the rat nucleus accumbens shell.
Delle Donne KT; Chan J; Boudin H; Pélaprat D; Rostène W; Pickel VM
Synapse; 2004 Jun; 52(3):176-87. PubMed ID: 15065218
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers.
Borroto-Escuela DO; Ravani A; Tarakanov AO; Brito I; Narvaez M; Romero-Fernandez W; Corrales F; Agnati LF; Tanganelli S; Ferraro L; Fuxe K
Biochem Biophys Res Commun; 2013 May; 435(1):140-6. PubMed ID: 23624386
[TBL] [Abstract][Full Text] [Related]
16. Differential allosteric modulation within dopamine D
Plach M; Schäfer T; Borroto-Escuela DO; Weikert D; Gmeiner P; Fuxe K; Friedland K
Sci Rep; 2019 Nov; 9(1):16312. PubMed ID: 31704949
[TBL] [Abstract][Full Text] [Related]
17. The discriminative stimulus effects of the neurotensin NTS1 receptor agonist PD149163 in rats: stimulus generalization testing with dopamine D1 and D2 receptor ligands.
Prus AJ; Schuck CJ; Rusch KR; Carey LM
Drug Dev Res; 2014 Mar; 75(2):47-58. PubMed ID: 24668440
[TBL] [Abstract][Full Text] [Related]
18. Neurotensin Induces Presynaptic Depression of D2 Dopamine Autoreceptor-Mediated Neurotransmission in Midbrain Dopaminergic Neurons.
Piccart E; Courtney NA; Branch SY; Ford CP; Beckstead MJ
J Neurosci; 2015 Aug; 35(31):11144-52. PubMed ID: 26245975
[TBL] [Abstract][Full Text] [Related]
19. Effect of amphetamine on extracellular concentrations of amino acids in striatum in neurotensin subtype 1 and 2 receptor null mice: a possible interaction between neurotensin receptors and amino acid systems for study of schizophrenia.
Li Z; Liang Y; Boules M; Gordillo A; Richelson E
Neuropharmacology; 2010 Jun; 58(7):1174-8. PubMed ID: 20193696
[TBL] [Abstract][Full Text] [Related]
20. Functional neuroanatomy of the ventral striopallidal GABA pathway. New sites of intervention in the treatment of schizophrenia.
O'Connor WT
J Neurosci Methods; 2001 Aug; 109(1):31-9. PubMed ID: 11489297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
